Akero Therapeutics Inc (NASDAQ:AKRO)

Delayed Data
As of 4:02pm ET
 -0.11 / -1.15%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Akero Therapeutics Inc have a median target of 47.50, with a high estimate of 62.00 and a low estimate of 26.00. The median estimate represents a +403.18% increase from the last price of 9.44.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Akero Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -16.55%
Growthannually -13.41%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.